-
Pomalidomide
API’s Name Indication Innovator Patent Expiry Date(The U.S) Pomalidomide Oncology drug Celgene -
Pitavastatin Calcium
API’s Name Indication Specification US DMF EU DMF CEP Pitavastatin Calcium Hypercholesterolemia In-House -
Pregabalin
API’s Name Indication Specification US DMF EU DMF CEP Pregabalin Epilepsy/Neuralgia In-House/EP 22223 √ CEP2016-141